sts2023.saudithoracicsociety.orgSTS 2023 International

Conference Your cart is currently empty About Welcome Message Committee Venue Faculty NATIONAL & REGIONAL FACULTIES INTERNATIONAL SPEAKERS Programs Who & Why Program at a Glance Pre-Conference Workshops Scientific Program Oncology Summit Abstract & Awards Why Submit an Abstract Abstract Guidelines Submit Abstract Awards Sponsors Registration Gallery Useful Information General Information Glimpse into Riyadh Accommodation Contact us Search for: Your cart is currently empty THANK YOU FOR JOINING STS 2023 INTERNATIONAL CONFERENCE Riyadh Contact Us Tel: +966-11-2488966 Email: admin@saudithoracicsociety.org Website: saudithoracicsociety.org Venue Riyadh Marriott Hotel 8333 King Saud Road, Al Wizarat District, Riyadh, Saudi Arabia, 12622 Copyright 2023 © STS 2023 error: Content is protected !! Hajar M. Al Hayyan, MBBS Riyadh, Saudi Arabia Consultant Pulmonary Medicine and Severe Airway Diseases King Abdulaziz Medical City Ministry of National Guard Health Affairs X Nashmia Almutairi, MD Riyadh, Saudi Arabia Deputy Chairman, Department of Oncology Section Head, Division of Gynecology Oncology King Abdulaziz Medical City Ministry of National Guard Health Affairs X Dr. Roberto Badagliacca, MD, PhD Italy Dr. Roberto Badagliacca is an associate professor of cardiology at Sapienza University of Rome. My research focus during and following my medical training has been on pulmonary arterial hypertension. I received advanced clinical and research training in cardiovascular diesease, cardiovascular imaging, and advanced heart failure. Since my appointment as Associate Professor of Cardiology, I have developed a specific interest in studying the pathophysiology, imaging phenotyping and risk stratification of pulmonary arterial hypertension. My research experience has culminated in the inclusion in the Nucleus of the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, in a variety of peer-reviewed publications in the area and the inclusion as a Task Force Member of important Guidelines and Consensus documents Committees: Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension” for the European Society of Cardiology and European Respiratory Society (2020-2022); Consensus Statement on Peri-operative Management of Patients with Pulmonary Hypertension and Right Heart Failure Undergoing Surgery” for the International Society of Heart and Lung Transplantation (2020-2022); Consensus Statement on Risk Stratification in Pulmonary Arterial Hypertension” for the International Society of Heart and Lung Transplantation (2022). X Hussein S. Al Juwayed, MD Riyadh, Saudi Arabia Consultant Pulmonary & Sleep Medicine Head, Asthma and Airway Diseases Unit Director, Adult Pulmonary Fellowship Program Division of Pulmonary Medicine Department of Medicine Prince Sultan Military Medical City X Doaa Gad, MBBS Riyadh, Saudi Arabia Consultant pulmonary Medicine Mouwasat Hospital X Shaden Qasrawi, MBBS, MSc (Resp Med), MRCP, SCE (Resp) Riyadh, Saudi Arabia Consultant Pulmonology and Sleep Medicine Kingdom Hospital X Bashayr M. Alotaibi, MD Riyadh, Saudi Arabia Assistance Professor of Medicine Consultant Pulmonology and Airway diseases King Saud University Medical City X Wael F. Albalawy, MD, SFAAI , FEAACI Riyadh, Saudi Arabia Consultant Allergy & Immunology King Saud Medical City X Fatmah Alhabeeb, MD Riyadh, Saudi Arabia Assistance Professor of Medicine Consultant Pulmonology and Airway diseases King Saud University Medical City X Rayyan M. ALMusally, MD Dammam, Saudi Arabia Assistant Professor of Medicine Consultant Pulmonary Medicine Imam Abdulrahman bin Faisal University X Fahad M. Alobaid, MD Riyadh, Saudi Arabia Consultant Pulmonary Medicine Interstitial Lung Disease Department of Medicine King Faisal Specialist Hospital &Research Center X Kaine Teme, BSc-RRT, MPH Dubai, UAE Clinical Education Manager MEA-T ResMed EPN Ltd X Mohmmed A. Algamdi, MBBS, FRCPC, ABIM, MHSc Riyadh, Saudi Arabia Consultant Pulmonary Medicine & Critical Care Medicine Interstitial Lung Disease King Fahad Medical City X Lamia G. Jamjoom, M.D, ABR Jeddah, Saudi Arabia Assistant Professor of Radiology President, Radiological Society of Saudi Arabia Consultant in cardiovascular and thoracic imaging King Abdulaziz University Hospital X Sultan A. Qanash Jeddah, Saudi Arabia Assistant professor of Medicine Consultant in Pulmonary and Sleep Medicine Director, Sleep Disorder Laboratory College of Medicine King Saud Bin Abdul-Aziz University for Health Sciences X Noura Alturaif, MD Riyadh, Saudi Arabia Associate Consultant Transplant Pulmonology and Pulmonary Hypertension Lung Health Department King Faisal Specialist Hospital & Research Center X Waleed Alharbi, MBBS, FRCPC, MPH Riyadh, Saudi Arabia Consultant Interventional Cardiologist Director of King Fahad Cardiac Center King Saud University Medical City X Rand K Arnaout, MBBS, FAAP, FAAAAI, ABP Riyadh, Saudi Arabia Assistant Professor (adj.) College of Medicine, Alfaisal University Head/ Consultant Allergy & Immunology Department of Medicine King Faisal Specialist Hospital &Research Center X Prof. Richard Gísli Jenkins PhD FRCP FERS UK Gisli Jenkins is a respiratory physician and cell & molecular biologist studying how the lung responds to injury to understand what drives progressive pulmonary fibrosis rather healing, repair and regeneration. He is an NIHR Research Professor, he leads the Margaret Turner Warwick Centre for Fibrosing Lung Diseases at the National Heart and Lung Institute and is an honorary consultant physician at the Royal Brompton Hospital, London. X Prof. Federico Lavorini, MD, PhD Italy Federico Lavorini is a Professor of Respiratory Medicine and Head of the Respiratory and Critical Care Unit at the Department of Clinical and Experimental Medicine, University of Florence, Italy. He qualified in Medicine at the University of Florence (1991), has the Specialist Certification in Respiratory Medicine (1996), and he also undertook a Ph.D. board certified in Respiratory Pathophysiology (2000). His research interests are cough pathophysiology and aerosol medicine, particularly the study of effectiveness of inhaler devices and their use by asthma and COPD in a real-life setting. Since 2022, Federico Lavorini has published over 150 peer-reviewed papers and 80 of them are in the field of aerosol medicine. He has extensive experience in both academic and industrial pharmaceutics, and still retains a strong link with the pharmaceutical industry. Recently, he patented a powder formulation of an antitussive drug deliverable by means of a capsule-based dry powder inhaler. Federico Lavorini is a member of the Aerosol Drug Management Improvement Team (ADMIT), an european consortium of respiratory physician with special interests in aerosol medicine. Federico Lavorini is Chairman of the Italian Respiratory Society (SIP) Taskforce on aerosol delivery systems; he was also Co-Chair of the Global Consortium of Standards for Inhaler Errors, an initiative by the Imperial College London, UK. Federico Lavorini is Associate Editor and Review Editor of the Respiratory Physiology and Pathophysiology, Frontiers in Physiology, and Canadian Respiratory Journal. Federico Lavorini acts as board member of the Journal of Aerosol Medicine and Pulmonary Drug Delivery and he is a contributor and reviewer for the Journal. Federico Lavorini presented several invited lectures on aerosol medicine topics in international meetings of the European Respiratory Society, American Thoracic Society, International Society of Aerosol Medicinea, RDD and DDL amomg others. X Prof. Pierluigi Paggiaro, MD Italy Full Professor of Respiratory Medicine at the University of Pisa from 2007 to 2018 and Chief of the Respiratory Pathophysiology and Pulmonary Rehabilitation Unit of the University Hospital of Pisa. Graduated in Medicine and Surgery at the University of Pisa in 1972, He post-graduated in Occupational Medicine (1974), Respiratory Medicine (1977) and Allergy...